logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
N

Nirav N. Shah

medical college of wisconsin
H指数:46
被引数:9,068

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Itacitinib plus calcineurin inhibitor–based therapy for prophylaxis of graft-versus-host disease: GRAVITAS-119 results

伊塔西替尼联合钙调神经磷酸酶抑制剂为基础的治疗预防移植物抗宿主病：GRAVITAS-119研究结果

Bone Marrow Transplantation
IF5.2
2026-10-070
PRE
Nirav N. Shah; Hannah Choe; Nancy M. Hardy; Patrice Chevallier; Marie-Therese Rubio; Mark A. Schroeder; Carlos Solano; Amelia Langston; Patrick Stiff; Kevin Hou; Michael Arbushites; Michael Pratta; Rodica Morariu-Zamfir; Miguel-Angel Perales
A Randomized Phase II Study of Subcutaneous Mosunetuzumab in Combination With Polatuzumab Vedotin Compared With Rituximab Plus Polatuzumab Vedotin in Patients With Relapsed or Refractory Large B-Cell Lymphoma

一项随机II期研究：皮下注射mosunetuzumab联合polatuzumab vedotin与利妥昔单抗联合polatuzumab vedotin治疗复发或难治性大B细胞淋巴瘤患者的比较研究

American Journal of Hematology
IF9.9
2026-07-280
OAAI
Julio C. Chavez; Mariana Bastos-Oreiro; Catherine Diefenbach; Izidore S. Lossos; Nirav Shah; Sarit Assouline; Adam J. Olszewski; Seema Naik; Nilanjan Ghosh; Song Pham; Michael C. Wei; Connie Batlevi; Iris To; Wahib Ead; Sneha Makadia; Elicia Penuel; Jing Jing; Lihua E. Budde
TIDRAKIZUMAB FOR THE PROPHYLAXIS OF GRAFT VERSUS HOST DISEASE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

替达拉珠单抗在异基因造血干细胞移植后移植物抗宿主病的预防中的应用

Blood Advances
IF7.1
2026-02-050
OAAI
Lyndsey Runaas; Salena Fank; Katie Palen; Aniko Szabo; Lisa E. Rein; Grace Ying; Nita Salzman; Lisa Samanas; Sameem Abedin; Saurabh Chhabra; Mehdi Hamadani; Walter Longo; Nirav N. Shah; Jennifer Haber; Ana Gradissimo; Nicholas Waters; Jonathan U. Peled; Bryon Johnson; Tyce Kearl; William R. Drobyski
Pirtobrutinib, a Highly Selective, Non-covalent (Reversible) BTKi in R/R Marginal Zone Lymphoma: Phase 1/2 BRUIN Study

Pirtobrutinib，R/R边缘区淋巴瘤中的高选择性，非共价 (可逆) BTKi: 1/2期布鲁因研究

Blood Advances
IF7.1
2026-01-200
OAAI
Krish Patel; Julie Vose; Sunita D. Nasta; Jennifer R. Brown; Kami Maddocks; Jennifer Woyach; Nirav N. Shah; Bita Fakhri; Benoit Tessoulin; Shuo Ma; Deepa Jagadeesh; Ewa Lech-Maranda; Catherine C. Coombs; Manish R. Patel; Joanna M. Rhodes; Chaitra Ujjani; Marc S. Hoffmann; Chan Y. Cheah; Talha Munir; David Lewis
Recommendations for Defining Chimeric Antigen Receptor T-Cell (CAR T) Dose-Limiting Toxicities (DLTs) for Future Early-Phase CAR T Therapy Studies

关于未来早期CAR T疗法研究中定义嵌合抗原受体T细胞（CAR T）剂量限制性毒性（DLTs）的建议

Transplantation and Cellular Therapy
IF4.4
2025-11-070
PRE
Frederick L. Locke; Sarah Nikiforow; Matthew J. Frigault; David G. Maloney; Marco Davila; David B. Miklos; Yi Lin; Judy Vong; Nirav N. Shah; Sattva S. Neelapu; John Welch; Eric Ng; Caron Jacobson; Marcela V. Maus
Erratum to <[Transplant Cell Ther. 2023 Jul;29(7):438.e1-438.e16. Epub 2023 Mar 9]>

勘误：《免疫效应细胞相关噬血细胞性淋巴组织细胞增多症样综合征》\[Transplant Cell Ther. 2023 Jul;29(7):438.e1-438.e16. Epub 2023 Mar 9\]

Transplantation and Cellular Therapy
IF4.4
2025-10-300
OAAI
Melissa R. Hines; Tristan E. Knight; Kevin O. McNerney; Mark B. Leick; Tania Jain; Sairah Ahmed; Matthew J. Frigault; Joshua A. Hill; Michael D. Jain; William T. Johnson; Yi Lin; Kris M. Mahadeo; Gabriela M. Maron; Rebecca A. Marsh; Sattva S. Neelapu; Sarah Nikiforow; Amanda K. Ombrello; Nirav N. Shah; Aimee C. Talleur; David Turicek; Anant Vatsayan; Sandy W. Wong; Marcela V. Maus; Krishna V. Komanduri; Nancy Berliner; Jan-Inge Henter; Miguel-Angel Perales; Noelle V. Frey; David T. Teachey; Matthew J. Frank; Nirali N. Shah
Genomic Determinants of Response and Resistance to Pirtobrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia

Pirtobrutinib对复发/难治性慢性淋巴细胞白血病的反应和耐药性的基因组决定因素

Blood
IF23.1
2025-10-100
OAAI
Jennifer R. Brown; Bastien Nguyen; Sai Prasad Desikan; Helen Won; Shady I. Tantawy; Samuel C. McNeely; Narasimha Marella; Hetal S. Randeria; Lauren M. Hanson; Andrew Parker; Salomé Calado Botelho; Jennifer A. Woyach; Krish Patel; Constantine S. Tam; Toby A. Eyre; Chan Y. Cheah; Nirav N. Shah; Paolo Ghia; Wojciech Jurczak; Minna Balbas; Binoj Nair; Paolo Abada; Chunxiao Wang; Denise Wang; Lindsey E. Roeker; Varsha Gandhi; William G. Wierda
Pan-UK Biobank genome-wide association analyses enhance discovery and resolution of ancestry-enriched effects

全英生物银行全基因组关联分析增强了祖先富集效应的发现和解析

Nature Genetics
IF0
2025-09-180
PRE
Konrad J. Karczewski; Rahul Gupta; Masahiro Kanai; Wenhan Lu; Kristin Tsuo; Ying Wang; Raymond K. Walters; Patrick Turley; Shawneequa Callier; Nirav N. Shah; Nikolas Baya; Duncan S. Palmer; Jacqueline I. Goldstein; Gopal Sarma; Matthew Solomonson; Nathan Cheng; Sam Bryant; Claire Churchhouse; Caroline M. Cusick; Timothy Poterba; John Compitello; Daniel King; Wei Zhou; Cotton Seed; Hilary K. Finucane; Mark J. Daly; Benjamin M. Neale; Elizabeth G. Atkinson; Alicia R. Martin
Pirtobrutinib, a Highly Selective, Non-covalent (Reversible) BTKi in R/R Follicular Lymphoma: Phase 1/2 BRUIN Study

Pirtobrutinib，一种高选择性、非共价（可逆）BTKi在复发/难治性滤泡性淋巴瘤中的应用：BRUIN研究1/2期

Blood Advances
IF7.1
2025-08-250
OAAI
Nirav N. Shah; Pier Luigi Zinzani; Michael Wang; Sunita D. Nasta; Ewa Lech-Maranda; Yoshiaki Ogawa; Bita Fakhri; Bryone Kuss; Kaname Miyashita; Krish Patel; Catherine C. Coombs; Shuo Ma; Manish R. Patel; Minal A. Barve; Benoit Tessoulin; Anastasios Stathis; Daisuke Ennishi; Daigo Hashimoto; Kensuke Kojima; Andrew D. Zelenetz
Chimeric Antigen Receptor T-cell Therapy for Richter Transformation: A CIBMTR analysis

嵌合抗原受体T细胞疗法治疗Richter转化：一项CIBMTR分析

Transplantation and Cellular Therapy
IF4.4
2025-08-050
PRE
Kalyan V. Nadiminti; Kwang W. Ahn; Jinalben Patel; Qinghua Lian; Evandro Bezerra; Andy Chen; Siddhartha Ganguly; Usama Gergis; Hamza Hashmi; Mohamed A. Kharfan-Dabaja; John Kuruvilla; Lazaros Lekakis; Frederick L. Locke; Hemant Murthy; Muhamad Alhaj Mousthafa; Miguel-Angel Perales; Priyanka Pophali; Peter A. Riedell; Nirav N. Shah; Trent Wang
A First-in-Human Phase I Study of LOXO-338, an Oral Selective Bcl-2 Inhibitor, in Patients With Advanced Hematologic Malignancies

一项关于LOXO-338（一种口服选择性Bcl-2抑制剂）在晚期血液系统恶性肿瘤患者中的首次人体I期研究

clinical lymphoma myeloma leukemia
IF0
2025-01-280
PRE
Michal Kwiatek; Guru Subramanian Guru Murthy; Marc Hoffmann; Benoit Tessoulin; Alexey Danilov; Alvaro J. Alencar; Nirav N. Shah; Hervé Ghesquieres; Steven Le Gouill; Wojciech Jurczak; Hongmei Han; Eunice Yuen; Vishalkumar Patel; Yingying Guo-Avrutin; James M. Pauff; Lindsey E. Roeker
Lack of Benefit of Autologous Hematopoietic Cell Transplantation (auto-HCT) in Mantle Cell Lymphoma (MCL) Patients (pts) in First Complete Remission (CR) with Undetectable Minimal Residual Disease (uMRD): Initial Report from the ECOG-ACRIN EA4151 Phase 3 Randomized Trial

自体造血细胞移植（auto-HCT）在无检测到的微小残留病（uMRD）的套细胞淋巴瘤（MCL）患者（pts）首次完全缓解（CR）中的获益不足：ECOG-ACRIN EA4151 III期随机试验的初步报告

BLOOD
IF23.1
2024-11-252
PRE
Fenske, Timothy S.; Wang, Xin Victoria; Till, Brian G.; Blum, Kristie A.; Lunning, Matthew; Lazarus, Hillard M.; Fishkin, Paul A. S.; Shields, Lale Kostakoglu; Scott, David W.; Lacasce, Ann S.; Johnston, Patrick B.; Cashen, Amanda F.; Popplewell, Leslie L.; Dean, Robert M.; Ahmed, Nausheen; Shah, Nirav N.; Wagner-Johnston, Nina D.; Hu, Boyu; Dholaria, Bhagirathbhai R.; Little, Richard F.; Friedberg, Jonathan W.; Leonard, John P.; Kahl, Brad S.

研究方向

暂未获取到该数据
M
Mehdi Hamadani
H 指数:68论文数:957被引数:1.9万
H
Hari, Parameswaran
H 指数:0论文数:2被引数:0
A
Anikó Szabó
H 指数:52论文数:570被引数:1.1万
S
Shuo Ma
H 指数:42论文数:304被引数:8,816
B
Bryon D. Johnson
H 指数:38论文数:271被引数:5,045
S
Saurabh Chhabra
H 指数:46论文数:444被引数:8,659
T
Timothy S. Fenske
H 指数:50论文数:405被引数:9,582
N
Narendranath Epperla
H 指数:31论文数:454被引数:3,495
A
Anita D’Souza
H 指数:44论文数:498被引数:7,873
S
Sairah Ahmed
H 指数:46论文数:663被引数:8,708